文献速递关节外科骨质疏松与代谢性骨病

骨关节炎初次全髋与全膝关节置换术后主要死因:332734例髋关节置换术后26766例死亡与384291例膝关节置换术后29802例死亡的队列研究

The Main Cause of Death Following Primary Total Hip and Knee Replacement for Osteoarthritis: A Cohort Study of 26,766 Deaths Following 332,734 Hip Replacements and 29,802 Deaths Following 384,291 Knee Replacements.
PubMed 文献 · J Bone Joint Surg Am · 2017-01-01

该队列研究比较2003至2012年英格兰、威尔士和北爱尔兰接受初次全髋或全膝关节置换的骨关节炎患者与年龄性别匹配的普通人群,发现全髋置换总体标准化死亡比0.61(95%CI 0.60-0.62),全膝置换0.57(95%CI 0.56-0.57);术后90天内缺血性心脏病是首位死因,消化系统疾病相关死亡风险在术后90天内明显升高。

要点

  • 全髋置换术后主要死因为恶性肿瘤(33.8%)、循环系统疾病(32.8%)、呼吸系统疾病(10.9%)和消化系统疾病(5.5%)。
  • 全膝置换术后主要死因为恶性肿瘤(33.3%)、循环系统疾病(33.3%)、呼吸系统疾病(9.8%)和消化系统疾病(5.3%)。
  • 术后90天内缺血性心脏病是全髋(29%)和全膝(31%)置换的首位死因,消化系统疾病相关死亡风险在术后90天内明显升高。

核心结论

  • 缺血性心脏病是全关节置换术后90天内的首位死因,且术后消化系统疾病相关死亡增加。
  • 针对减少这些疾病的干预可能对降低全关节置换患者的死亡率影响最大。

研究设计与样本

  • 比较2003年至2012年英格兰、威尔士和北爱尔兰接受初次全髋或全膝关节置换的骨关节炎患者与年龄性别匹配的普通人群的死亡原因和死亡率。
  • 全髋置换组332734例(其中26766例在删失日期前死亡),全膝置换组384291例(其中29802例在删失日期前死亡)。

主要发现

  • 全髋置换术后死因:恶性肿瘤33.8%(9037/26766)、循环系统疾病32.8%(8784/26766)、呼吸系统疾病10.9%(2928/26766)、消化系统疾病5.5%(1465/26766)。
  • 全膝置换术后死因:恶性肿瘤33.3%(9917/29802)、循环系统疾病33.3%(9932/29802)、呼吸系统疾病9.8%(2932/29802)、消化系统疾病5.3%(1572/29802)。
  • 全髋置换总体标准化死亡比0.61(95%CI 0.60-0.62),相对普通人群死亡率降低39%,至7年时与普通人群死亡率持平。
  • 全膝置换总体标准化死亡比0.57(95%CI 0.56-0.57),相对普通人群死亡率降低43%,至7年时部分减弱但仍未与普通人群死亡率持平。
  • 术后90天内首位死因为缺血性心脏病,全髋置换占29%(431例),全膝置换占31%(436例);术后90天内循环系统、呼吸系统和消化系统(最明显)相关死亡风险高于术后91天至1年。

关键数值与推荐

  • 全髋置换总体标准化死亡比0.61(95%CI 0.60-0.62),全膝置换0.57(95%CI 0.56-0.57)。
  • 全髋置换术后90天内缺血性心脏病死亡占29%(431例),全膝置换占31%(436例)。
  • 证据等级:治疗性III级。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients undergoing primary total joint replacement are selected for surgery and thus (other than having a transiently increased mortality rate postoperatively) have a lower mortality rate than age and sex-matched individuals do. Understanding the causes of death following joint replacement would allow targeted strategies to reduce the risk of death and optimize outcome. We aimed to determine the rates and causes of mortality for patients undergoing primary total hip or knee replacement compared with individuals in the general population who were matched for age and sex. METHODS: We compared causes and rates of mortality between age and sex-matched individuals in the general population (National Joint Registry for England, Wales and Northern Ireland; Hospital Episode Statistics; and Office for National Statistics) and a linked cohort of 332,734 patients managed with total hip replacement (26,766 of whom died before the censoring date) and 384,291 patients managed with primary total knee replacement (29,802 of whom died before the censoring date) from 2003 through 2012. RESULTS: The main causes of death were malignant neoplasms (33.8% [9,037] of 26,766 deaths in patients with total hip replacement and 33.3% [9,917] of 29,802 deaths in patients with total knee replacement), circulatory system disorders (32.8% [8,784] of the deaths in patients with total hip replacement and 33.3% [9,932] of the deaths in patients with total knee replacement), respiratory system disorders (10.9% [2,928] of the deaths in patients with total hip replacement and 9.8% [2,932] of the deaths in patients with total knee replacement), and digestive system diseases (5.5% [1,465] of the deaths in patients with total hip replacement and 5.3% [1,572] of the deaths in patients with total knee replacement). There was a relative reduction in mortality (39%) compared with the individuals in the general population that equalized to the rate in the general population by 7 years for hips (overall standardized mortality ratio [SMR], 0.61; 95% confidence interval [CI], 0.60 to 0.62); for knees, the relative reduction (43%) partially attenuated by 7 years but still had not equalized to the rate in the general population (overall SMR, 0.57; 95% CI, 0.56 to 0.57). Ischemic heart disease was the most common cause of death within 90 days (29% [431] of the deaths in patients with primary hip replacement and 31% [436] of the deaths in patients with primary knee replacement). There was an elevated risk of death from circulatory, respiratory, and (most markedly) digestive system-related causes within 90 days postoperatively compared with 91 days to 1 year postoperatively. CONCLUSIONS: Ischemic heart disease is the leading cause of death in the 90 days following total joint replacement, and there is an increase in postoperative deaths associated with digestive system-related disease following joint replacement. Interventions targeted at reducing these diseases may have the largest effect on mortality in total joint replacement patients. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Hunt LP, Ben-Shlomo Y, Whitehouse MR, et al. The Main Cause of Death Following Primary Total Hip and Knee Replacement for Osteoarthritis: A Cohort Study of 26,766 Deaths Following 332,734 Hip Replacements and 29,802 Deaths Following 384,291 Knee Replacements. J Bone Joint Surg Am. 2017. PMID: 28375889. doi:10.2106/JBJS.16.00586

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。